↓ Skip to main content

Tele-Mum: A Feasibility Study for a Randomized Controlled Trial Exploring the Potential for Telemedicine in the Diabetes Care of Those with Gestational Diabetes

Overview of attention for article published in Diabetes Technology & Therapeutics, December 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

blogs
1 blog
twitter
2 tweeters

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
162 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Tele-Mum: A Feasibility Study for a Randomized Controlled Trial Exploring the Potential for Telemedicine in the Diabetes Care of Those with Gestational Diabetes
Published in
Diabetes Technology & Therapeutics, December 2015
DOI 10.1089/dia.2015.0147
Pubmed ID
Authors

Joanne E. Given, Brendan P. Bunting, Maurice J. O'Kane, Fidelma Dunne, Vivien E. Coates

Abstract

The incidence of gestational diabetes mellitus (GDM)-hyperglycemia with onset or first recognition during pregnancy-is increasing and will have a significant impact on diabetes services. This study aimed to determine the feasibility and acceptability of using telemedicine in the diabetes care of women with GDM and the possibility of replacing alternate (one in every two) diabetes review appointments with telemedicine. A feasibility study for a randomized controlled trial was conducted across two sites. Fifty women with GDM were randomized to usual care (n = 26) or usual care plus telemedicine (n = 24). Telemedicine entailed weekly blood pressure and weight measurements and transmission of these data, along with blood glucose readings, for review by the healthcare team. Patients were contacted about these results as necessary. Patients completed questionnaires to measure their satisfaction with telemedicine or blood glucose monitoring. The intervention group and healthcare providers also took part in qualitative interviews. Analysis involved descriptive statistics for the satisfaction questionnaires and framework analysis for the qualitative interviews. Eighty-nine percent of patients were satisfied with telemedicine and would use it again. Both HCPs and patients found the equipment easy to use and were positive about using it to replace alternate diabetes review appointments in the future. If used in this way, healthcare providers felt that protected time in which to perform the telemedicine review would be necessary. Telemedicine may help meet the growing demand on diabetes services due to increasing numbers of women being diagnosed with GDM.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 162 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Italy 1 <1%
Unknown 160 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 18%
Student > Bachelor 25 15%
Student > Ph. D. Student 23 14%
Researcher 15 9%
Student > Doctoral Student 11 7%
Other 26 16%
Unknown 33 20%
Readers by discipline Count As %
Medicine and Dentistry 54 33%
Nursing and Health Professions 24 15%
Psychology 15 9%
Social Sciences 7 4%
Agricultural and Biological Sciences 5 3%
Other 20 12%
Unknown 37 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2020.
All research outputs
#2,857,633
of 17,067,437 outputs
Outputs from Diabetes Technology & Therapeutics
#248
of 1,169 outputs
Outputs of similar age
#47,121
of 254,430 outputs
Outputs of similar age from Diabetes Technology & Therapeutics
#6
of 12 outputs
Altmetric has tracked 17,067,437 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,169 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 254,430 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.